MedTrace Logo

Evaluation of Brain Damage Due to Coronary Angioplasty in Percutaneous Intervention Patients

NCT04734587 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-10-06

No results posted yet for this study

Summary

This study examines the formation mechanism and patient-related factors of silent cerebral infarcts, whose importance has become increasingly recognized in patients undergoing percutaneous coronary intervention.

Conditions

  • Silent Stroke
  • Coronary Disease

Interventions

DIAGNOSTIC_TEST

Blood serum Neuron-specific Enolase measurement

The Silent Brain Injury ratio was compared by measuring the Neuron-specific enzyme level with venous blood sampling from both patient groups before and after percutaneous coronary intervention.

Sponsors & Collaborators

  • Ondokuz Mayıs University

    lead OTHER

Principal Investigators

  • Muhammet Uyanık, M.D. · Ondokuz Mayıs University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-18
Primary Completion
2020-03-25
Completion
2020-03-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04734587 on ClinicalTrials.gov